Roche has acquired PathAI for $750 million upfront, with potential additional payments of $300 million based on achieving certain milestones. This move accelerates Roche's integration of AI in pathology, offering developers and tech professionals new opportunities in medical diagnostics and AI applications. The acquisition signals a push towards broader implementation of AI-powered diagnostic tools globally.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



